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Abstract
Background: Myocardial contractile failure in septic shock may develop following direct interactions, within the heart itself,
between molecular motifs released by pathogens and their specific receptors, notably those belonging to the toll-like
receptor (TLR) family. Here, we determined the ability of bacterial flagellin, the ligand of mammalian TLR5, to trigger
myocardial inflammation and contractile dysfunction.
Methodology/Principal Findings: TLR5 expression was determined in H9c2 cardiac myoblasts, in primary rat
cardiomyocytes, and in whole heart extracts from rodents and humans. The ability of flagellin to activate pro-inflammatory
signaling pathways (NF-kappaB and MAP kinases) and the expression of inflammatory cytokines was investigated in H9c2
cells, and, in part, in primary cardiomyocytes, as well as in the mouse myocardium in vivo. The influence of flagellin on left
ventricular function was evaluated in mice by a conductance pressure-volume catheter. Cardiomyoyctes and intact
myocardium disclosed significant TLR5 expression. In vitro, flagellin activated NF-kappaB, MAP kinases, and the transcription
of inflammatory genes. In vivo, flagellin induced cardiac activation of NF-kappaB, expression of inflammatory cytokines (TNF
alpha, IL-1 beta, IL-6, MIP-2 and MCP-1), and provoked a state of reversible myocardial dysfunction, characterized by cardiac
dilation, reduced ejection fraction, and decreased end-systolic elastance.
Conclusion/Significance: These results are the first to indicate that flagellin has the ability to trigger cardiac innate immune
responses and to acutely depress myocardial contractility.
Citation: Rolli J, Rosenblatt-Velin N, Li J, Loukili N, Levrand S, et al. (2010) Bacterial Flagellin Triggers Cardiac Innate Immune Responses and Acute Contractile
Dysfunction. PLoS ONE 5(9): e12687. doi:10.1371/journal.pone.0012687
Editor: Ludovic Tailleux, Institut Pasteur, France
Received April 20, 2010; Accepted July 26, 2010; Published September 13, 2010
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This work was supported by grants from the Swiss National Fund for Scientific Research (PP00B-68882/1 and 320000-118174/1) to Lucas Liaudet. URL:
www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lucas.liaudet@chuv.ch
Introduction
Septic shock, characterized by systemic inflammation and
cardiovascular collapse, is triggered upon the recognition of
pathogen-associated molecular patterns (PAMPs) by pattern
recognition receptors (PRRs) [1]. Toll-like Receptors (TLRs)
represent a major family of PRRs, playing a front-line role in host
defenses by inducing innate immune responses through nuclear
factor kappa B (NF-kB) signaling [2], as well as through members
of the mitogen-activated protein kinase (MAPK) family [3,4].
One of the vital organs adversely affected in septic shock is the
heart [5]. Myocardial contractile failure occurs in 24 to 44% of
patients with septic shock [6]. Its pathogenic mechanisms remain
largely unknown, although it is established that pro-inflamma-
tory cytokines such as TNFa and IL-1b are potent cardiode-
pressant effectors [7]. Recent findings indicate that the heart
expresses several TLRs, implying that it may sense bacterial
PAMPs to mount its own immune response and promote its own
dysfunction [8]. Indeed, studies reported that lipopolysaccharide
(LPS) from Gram-negative bacteria induced myocardial inflam-
mation and cardiac dysfunction by interacting with its ligands,
CD14 and TLR4, on cardiomyocytes [9,10]. The relevance of
these results is, however, questionable, as they were obtained
with very high doses of LPS (25 mg/kg) and relied on indirect,
load-dependent, indices of cardiac contractility. In fact, several
animal studies using load-independent measurements of cardiac
contractiliy could not reproduce such direct negative inotropic
effects of LPS [11,12]. Beside LPS, most Gram-negative bacteria
also release substantial amounts of flagellin, the main structural
protein of the bacterial flagellum [13]. Flagellin elicits immune
responses upon binding to its receptor, TLR5 [14], expressed by
immune and various epithelial cells [13,15,16], induces systemic
inflammation in rodents [13,14,17], and circulates in significant
concentrations in the plasma of septic shock patients [18]. Given
these different properties, we hypothesized that flagellin might
trigger innate immune responses in the heart and represent a
potential mediator of myocardial contractile dysfunction in
sepsis.
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Results
Cardiomyocytes express TLR5
In H9c2 cells, we detected both TLR5 mRNA (Fig. 1A) and
TLR5 protein (Fig. 1B and C), migrating at approximately
100 kDa (reported size of TLR5: 97 kDa [19]). TLR5 mRNA was
detected in rat and mouse hearts (Fig. 1D), and TLR5 protein was
also expressed in primary ventricular cardiomyocytes, and in
mouse and human hearts (Fig. 1E).
Flagellin activates NF-kB in cultured cardiomyocytes
The engagement of TLR5 upon flagellin binding initiates a
signaling cascade leading to the activation of NF-kB [13]. TLR
signaling activates the upstream inhibitor of NF-kB kinase (IKK),
which induces phosphorylation and degradation of the inhibitor
IkBa, allowing NF-kB nuclear translocation [20]. In H9c2 cells,
flagellin induced transient activation of IKK peaking at 15 minutes
(Fig. 2A), associated with phosphorylation and degradation of
IkBa (Fig. 2B), followed by IkBa resynthesis after 60 minutes for
negative feedback [21]. NF-kB activation was confirmed by the
nuclear translocation of NF-kB p65 subunit (Fig. 2C) and NF-kB -
DNA binding (Fig. 2D). These effects of flagellin could not be
related to any LPS contamination, since LPS concentration in the
flagellin preparation measured by the Limulus assay was negligible
(,15 pg LPS/50 ng flagellin) and since the LPS binding agent
polymyxin B did not affect IkBa phosphorylation induced by
flagellin (Fig. 2E).
In primary rat ventricular cardiomyocytes, flagellin (50 ng/ml)
also induced nuclear p65 translocation and NF-kB-DNA binding
(Fig. 3A and B). There was no further increase in NF-kB-DNA
binding at higher flagellin concentrations (up to 500 ng/ml)
(Fig. 3C). NF-kB activation produced by LPS at similar
concentrations (50–500 ng/ml) was less pronounced than with
flagellin. The activation of NF-kB by flagellin was entirely
dependent on an intact TLR5-dependent signaling, as indicated
by the lack of NF-kB activation in TLR5 KO cardiomyocytes,
contrasting with a strong activation in WT cardiomyocytes
(Fig. 3D)
Flagellin induces transcription of NF-kB-dependent
genes in H9c2 cells
Flagellin increased the transcription of a transfected NF-kB-
dependent luciferase gene in H9c2 cells (Fig. 4A), with a threshold
inducing concentration of only 1 ng/ml (Fig. 4B), and also
promoted the transcription of the NF-kB-dependent genes TNFa
and MIP-2 (Fig. 4C), the latter being secreted in H9c2
supernatants (Fig. 4D).
Flagellin activates MAPK signaling pathway in H9c2 cells
Since the interaction of PAMPs with TLRs also triggers
activation of the mitogen-activated protein kinases p38 and c-
Jun NH2-terminal kinase (JNKs) [3,4], the effects of flagellin on
this signaling cascade was evaluated. As shown in Fig. 5A and
B, flagellin activated the phosphorylation of both p38 and JNK
in H9c2 cells, and also enhanced the binding of AP-1 to its
DNA-response element, known to be activated by JNK
(Fig. 5C).
Flagellin activates NF-kB and pro-inflammatory signaling
in the mouse heart in vivo, but does not trigger
significant myocardial cell death
Injection of 1 or 5 mg (respectively 40 or 200 mg/kg) flagellin to
BALB/c mice robustly induced IkBa phosphorylation and
degradation (Fig. 6A), p65 nuclear translocation (Fig. 6B) and
NF-kB-DNA binding (Fig. 6C) in whole heart within 30 minutes.
Specificity of the NF-kB-DNA binding was ascertained by cold
competition experiments (Fig. 6D). The threshold NF-kB-inducing
dose of flagellin was 10 ng per mouse (400 ng/kg; Fig. 6E). In
time-course experiments, NF-kB was activated in the heart as
early as 10 minutes after the injection of flagellin (Fig. 6F).
Flagellin did not induce myocardial cell death (necrotic or
apoptotic), as indicated by the lack of increase of serum troponin
(Fig. 6G) and the lack of cleavage of caspase-3 (Fig. 6H), the main
executioner apoptotic caspase, up to 24 hours after the injection of
flagellin. As a positive control, cardiac tissue was obtained
following myocardial ischemia-reperfusion in rats, which strongly
activates caspase-3 cleavage [22].
Figure 1. Expression of TLR5 by cultured cardiomyocytes and whole heart tissue. A, RT-PCR analysis of tlr5 transcription on H9c2 total RNA.
C-, negative control (no RNA); C+, positive control. Sizes of the amplified fragments: 310 bp (C+); 381 bp (TLR)5. B, TLR5 protein expression in H9c2
cells. Total proteins (TP), membrane proteins (MP), nuclear proteins (NP). C, Immunofluorescence detected the presence of TLR5 in H9c2 cells. Normal
rabbit serum (left) instead of anti-TLR5 antibody for negative control. Scale bar size: 10 mm. D, RT-PCR analysis of tlr5 transcription in rat and mouse
heart. E, Constitutive expression of TLR5 protein in H9c2, rat primary ventricular cardiomyocytes (CM), and mouse and human heart.
doi:10.1371/journal.pone.0012687.g001
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Flagellin induced significant cardiac expression of TNFa, IL-1b,
IL-6, MIP-2 and MCP-1 (Fig. 7A–E). This was associated with
modest cardiac recruitment of leukocytes, as evidenced by a
slightly increased activity of myeloperoxidase (Fig. 7G), the
presence of rare polymorphonuclear cells (PMN) in cardiac blood
vessels after 4 hours (Fig. 7H), and an increased Mac-3
immunoreactivity in the subepicardial region after 4 and 24 h
(Fig. 7I), pointing to some infiltrating mononuclear cells. The
Figure 2. Flagellin activates the IKK/NF-kB signaling pathway in H9C2 cardiomyocytes. H9c2 cells were unstimulated (control, C) or
stimulated with flagellin (50 ng/ml) for 5 to 120 minutes. A, IKK Kinase assay (KA) showing increased IKK activity after flagellin, starting at 10 minutes.
IKKb immunoblot (IB), loading control. B–C, IkBa phosphorylation and degradation, and p65 nuclear translocation are elicited by flagellin. a-tubulin,
loading control. D, Increased NF-kB-DNA binding activity elicited by flagellin, peaking at 30 minutes. E, Polymyxin B did not block IkBa
phosphorylation by flagellin but blocked that triggered by LPS. a-tubulin, loading control. * p,0.05 versus control C (ANOVA followed by Dunnett
test).
doi:10.1371/journal.pone.0012687.g002
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degree of activation of these cells appeared limited, as supported
by the lack of increase of soluble TREM-1, a biomarker of myeloid
cell activation [23], in cardiac tissue (Fig. 7F).
The inflammatory response triggered by flagellin was not
restricted to the heart, as indicated by marked elevations of TNFa,
IL-1b, and MIP-2 also noted in the lung and liver, as well as a
significant increase of circulating cytokines, as measured 1 h after
the administration of flagellin (Fig. 8), in line with other reports on
the effects of flagellin at the systemic level [13,17]. The cytokine
response of the heart was comparable to that of the liver, but was
less pronounced than that of the lung, which agrees with previous
findings on flagellin-induced pulmonary inflammation [18].
Flagellin impairs cardiac function in vivo
Flagellin induced, after 4 and 24 hours, significant increases in
end-systolic and end-diastolic LV volumes (Fig. 9A and B). LV
systolic pressure significantly decreased only at 4 hours, and there
was a trend towards increased LV end-diastolic pressure at 4 and
24 hours (Fig. 9C and D). There was a significant reduction in
ejection fraction, with no change in stroke volume (Fig. 9 E and F).
After 48 hours, all the different variables had returned to values
comparable to those of control animals.
Most importantly, flagellin provoked direct negative inotropic
effects, as evidenced by reductions of end-systolic elastance (Ees)-
the slope of the LV end-systolic PV relationship, (Fig. 9G, with
representative PV loops in the 4 groups of animals depicted in
Fig. 9I), and of time-varying elastance, or maximal elastance,
Emax (Fig. 9H). These changes, noted after 4 and 24 hours were
no more observable at 48 hours.
Discussion
The main characteristics of septic cardiomyopathy are depressed
contractility, reduced LV ejection fraction and bi-ventricular dilation
[7]. Recent studies have indicated that intrinsic alterations within
cardiac myocytes are key mechanisms of this acute heart failure,
which may be mediated by cardiac TLRs [8]. Cardiac myocytes
express several TLRs [8], and several TLR ligands -LPS,
peptidoglycan and bacterial DNA- activate NF-kB in these cells,
respectively through activation of TLR4, TLR2 and TLR9, leading
to the production of inflammatory mediators and alterations in
normal cardiac physiology [9,24,25]. In the present study, we extend
further this emerging concept, by showing that bacterial flagellin, the
ligand of mammalian TLR5 [13,14,17], is a potent inducer of
cardiac innate immune responses and contractile dysfunction.
Our results are the first to formally demonstrate that the heart
expresses TLR5. Although the presence of TLR5 mRNA had
been previously reported in the HL-1 cardiac cell line [26], we
now show that TLR5 protein is expressed in vitro both by H9c2
cells and primary ventricular myocytes, and that it is also strongly
expressed in cardiac tissue. Cardiac TLR5 expression was not
restricted to mice and rats, but was also observed in humans,
indicating that the ability of the heart to detect flagellin is not
species-related.
Figure 3. Flagellin activates NF-kB in primary murine cardiomyocytes via TLR5. A–B, Nuclear translocation of p65 and NF-kB-DNA binding
triggered by flagellin in primary rat ventricular myocytes after 30 minutes. C, Concentration-response experiments of NF-kB-DNA binding in primary
rat cardiomyocytes exposed either to flagellin or LPS (both at 50 ng/ml or 500 ng/ml) for 30 minutes. * p,0.05 versus control C (t test).
doi:10.1371/journal.pone.0012687.g003
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In vitro, minute concentrations of flagellin activated NF-kB in
H9c2 cells and primary cardiomyocytes, substantiating the
presence of an intact TLR5-dependent signaling system in cardiac
myocytes. The essential role of TLR5 in the process of NF-kB
activation elicited by flagellin was clearly evidenced by the lack of
NF-kB activation in primary murine cardiomyocytes isolated from
neonatal TLR5 deficient mice. Flagellin also activated two major
stress activated kinases, p38 and JNK, which may play a role in
septic cardiomyopathy, notably by activating the production of
TNFa within the myocardium [27,28]. Taken together, these data
indicate that recognition of extracellular flagellin by cells from
cardiac origin triggers signaling cascades intimately linked with the
development of cardiac dysfunction in sepsis.
In line with these in vitro results, flagellin also provoked major
inflammatory changes in the heart in vivo, characterized by a
robust activation of NF-kB, and the upregulation of the
inflammatory cytokines TNFa, IL-1b, IL-6, MIP-2 and MCP-1
within the cardiac tissue. In accordance with the roles of MIP-2
and MCP-1 as chemokines attracting polymorphonuclear cells
(PMN), respectively monocytes/macrophages, we found some
recruitment of poly- and mononuclear cells in the heart after
flagellin administration. The degree of activation of these
infiltrating cells appeared, however, limited, given the modest
increase in myeloperoxydase activity, and the lack of increase of
cardiac TREM-1, a specific cytokine derived from myeloid cells
[23], suggesting that the cardiac inflammatory phenotype
triggered by flagellin did not result primarily from the activation
of infiltrating inflammatory cells.
It must be underscored that NF-kB was activated extremely
early upon the injection of flagellin, as shown by stimulated
DNA-binding activity starting 10 minutes after the injection of
flagellin. Such immediate response supports the hypothesis that
cardiac inflammation was a direct consequence of flagellin-heart
interactions rather than an indirect effect due to the remote
generation of inflammatory mediators. Furthermore, NF-kB
activation occurred at very low concentrations of flagellin, as
indicated by a threshold-inducing dose of 10 ng/mouse (0.4 mg/
kg), which are clinically relevant, given that plasma levels of free
circulating flagellin between 2 and 16 mg/l have been detected
in humans with septic shock [17]. Overall, these findings
indicate that the heart is equipped to immediately recognize
circulating flagellin with high sensitivity, implying that this
bacterial protein may represent a particularly critical danger
signal in this organ.
It is currently assumed that the local upregulation, within the
heart itself, of inflammatory cytokines with negative inotropic
properties, including TNFa, IL-1b [6], and IL-6, [29], as well as
the cardiac recruitment of inflammatory cells, mostly polymor-
phonuclear cells [30], are key mechanisms leading to cardiac
dysfunction in sepsis. The strong immune response of the heart in
response to flagellin prompted us therefore to evaluate whether it
would also affect cardiac physiology. To address this question, a
microtip pressure volume (PV) conductance catheter was inserted
into the left ventricle (LV) of mice, 4, 24 or 48 hours after an iv
challenge with 1 mg (40 mg/kg) flagellin. In contrast to other
methods, which provide indirect, load-dependent, indices of
contractility, PV catheters allow the direct assessment of
contractility by computing the slope of the LV end-systolic PV
relationship (ESPVR), known as end-systolic elastance (Ees), which
is independent from preload and afterload [31].
Figure 4. Transcription of NF-kB-dependent genes in H9c2 cells after flagellin challenge. A, Time-course experiments. Luciferase activity
was maximally induced after 2 to 4 hours of flagellin (50 ng/ml). B, Dose-response experiments. Luciferase activity was slightly induced by 1 ng/ml
flagellin and maximally induced by 50 ng/ml flagellin (4 hours). C, Transcript levels of TNFa and MIP-2 mRNA (RT-PCR) in unstimulated cells (control,
C) and after flagellin (50 ng/ml, 1 hour). GAPDH, control. D, Flagellin induced synthesis and secretion of MIP-2 by H9C2 cells (ELISA). * p,0.05 versus
control C (ANOVA followed by Dunnett test A and B; t-test, D).
doi:10.1371/journal.pone.0012687.g004
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We could thus demonstrate that flagellin promotes the
depression of cardiac contractility, as evidenced by cardiac
dilation and reduced ejection fraction. These alterations were
related to a direct negative inotropic effect, attested by significant
reductions of both Ees and time-varying elastance, Emax. An
important aspect of the cardiac dysfunction provoked by flagellin
was its reversibility, as indicated by maximal systolic depression at
4 hours, followed by progressive recovery over a 48 hours period,
a pattern which is highly consistent with the transient nature of
septic myocardial dysfunction reported both in humans and in
large aninal models of sepsis [5,32]. Such reversibility argues
against the development of significant cardiac damage upon
flagellin administration. Indeed, we could not detect caspase
activation in the heart and we did not notice any increase in
plasma troponin I after flagellin, while systolic function was
already significantly altered. This is in agreement with the lack of
significant myocardial necrosis or apoptosis reported in animal
models and in postmortem studies in septic shock patients,
indicating that myocardial cell death is insufficient to account
for the functional depression observed, as recently reviewed [6].
Although flagellin clearly depressed myocardial contractile
function, our findings do not allow the conclusion that flagellin
Figure 5. Flagellin activates MAP kinase signaling in H9c2 cells. A, Flagellin induced p38 phosphorylation from 20 to 60 minutes. Total p38
remained unchanged. B, Phosphorylation of JNK was triggered by flagellin after 20 minutes. Total JNK1 remained unchanged. C, Flagellin triggered
AP-1-DNA binding activity with a peak at 30 minutes. NSB: non-specific band. * p,0.05 versus control C (ANOVA followed by Dunnett test).
doi:10.1371/journal.pone.0012687.g005
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may be the causal factor in the development of cardiac dysfunction
in sepsis. As stated earlier, many other factors released by bacteria
may also promote myocardial inflammation and cardiac dysfunc-
tion, including bacterial DNA, lipopolysacharride and peptidogly-
can. It is therefore highly likely that the depression of contractile
function during sepsis is the result of the concerted action of
multiple microbial virulence factors, each promoting intracellular
innate immune defense mechanisms by interacting with distinct
TLRs. To further precise the role of flagellin in the cardiac
depression of bacterial sepsis would therefore require additional
experiments using whole cell bacteria in TLR5 deficient mice,
which should be performed in future studies.
Several limitations of our study deserve further discussion. Firstly,
we cannot rule out that cells from non myocyte origin, mostly
vascular endothelial and smooth muscle cells, as well as cardiac
fibroblasts, may have contributed to the observed effects of flagellin
in vivo. Secondly, our study may be criticized due to the lack of
experiments in TLR5-deficient mice. However, these animals being
unresponsive to flagellin [16], they would not allow to get further
insights into the effects of flagellin on the heart. Cardiomyocyte-
specific TLR5-knockout mice should therefore be developed in the
future to further precise the actions of flagellin on this subset of
cardiac cells. Thirdly, our findings do not prove that the depression
of cardiac contractility observed after flagellin was a direct
consequence of the cardiac immune response to flagellin. Indeed,
the innate immune response to flagellin was not restricted to the
heart, but instead was a widespread phenomenon, as shown by the
rise of cytokines in other organs such as the lung and liver as well as
the increase of circulating inflammatory mediators. Therefore, the
contractile dysfunction observed upon flagellin administration
cannot be simply attributed to a purely localized, cardiac restricted
inflammation, but should be viewed as one component of the
systemic innate immune response to this bacterial protein. In
conclusion, our results collectively indicate that bacterial flagellin
induces a prototypical innate immune response in cells from cardiac
origin in vitro and in the whole heart in vivo, and that this response
is associated with the development of an acute, transient and
reversible, contractile dysfunction, which resembles the clinical
picture of septic myocardial dysfunction.
Materials and Methods
Ethics Statement
All procedures involving animals complied with the Swiss laws on
animal experimentation and were authorized by our institutional
ethical committee for animal research (Veterinary Office of the State of
Vaud, Department of Economy-Authorization Number 1827.0). The
sampling of cardiac tissue from human patients at the time of cardiac
surgery was approved by the ethical committee of the University of
Lausanne, and written-informed consent was obtained from patients.
Cell culture conditions and cell stimulations
H9c2 cells, a clonal cell line derived from rat heart retaining
many biochemical and physiological aspects of adult rat
cardiocytes [33] were grown as mentioned [22]. Key experiments
were also performed in primary adult rat ventricular myocytes,
isolated according to our published procedures [34], and also in
primary cardiomyocytes obtained from neonatal wild-type and
TLR5 deficient mice [35], according to previously published
procedures [36]. Briefly, ventricles were separated from the atria,
minced and digested in buffer containing 0.45 mg/ml collagenase
(Worthington Biochemical Corporation) and 1 mg/ml pancreatin
(Invitrogen Life Technologies). Cardiomyocytes were separated
from non myocyte cells by two steps of differential plating at
45 min each, and were then plated on gelatinized plates in a 3:1
mixture of DMEM and Medium 199 (Invitrogen life Technolo-
gies) supplemented with 10% horse serum (Serotech Ltd, Oxford,
UK), 5% fetal bovine serum (FBS) (Serotech Ltd), 100 U/ml
penicillin G, and 100 g/ml streptomycin. Cardiomyocytes were
allowed to adhere overnight, and then maintained in serum-free
medium with antibiotics before their stimulation with flagellin.
Cells were stimulated with 1–500 ng/ml Salmonella muenchen
flagellin (Calbiochem, San Diego, CA), or 50–1000 ng/ml
Salmonella enteritidis LPS (Sigma-Aldrich, Basel, Switzerland). In
some experiments, flagellin or LPS were incubated for 10 minutes
with polymyxin B (10 mg/ml) before use. Wild-type and TLR5
KO cardiomyocytes were left unstimulated or were stimulated
with flagellin at 50 ng/ml for 30 minutes.
Administration of flagellin to conscious mice
Male BALB/c mice (23–26 g) were injected (tail vein) with
flagellin (40 ng/kg to 200 mg/kg) or vehicle (0.2 ml saline). At
selected time-points, mice were used for hemodynamic measure-
ments or were sacrificed to obtain hearts for biochemical analyses.
Cardiac tissue sampling in humans
Human right atrial samples were obtained at the time of right
atrial canulation during heart surgery.
Immunoblot analyses
Total and nuclear protein extracts were prepared as described
[21], and membrane-associated proteins were obtained after
ultracentrifugation. SDS-PAGE and immunoblotting was performed
as mentioned [20] using the following antibodies: anti-IkBa, anti-
phospho-IkBa, anti-NF-kB RelA/p65, anti-JNK1, anti-p38 (Santa-
Cruz Biotechnology, Santa Cruz, CA), anti-phospho-JNK1/2, anti-
phospho-p38, anti-caspase-3, anti-a-tubulin (Cell signaling, Beverly,
MA) and anti-TLR5 (Biovision Inc., Mountain View, CA).
Electromobility Shift Assay (EMSA)
EMSA was performed as described [20], with an NF-kB
oligonucleotide probe (59-GGCAGTTGAAGGGGACTTTCC-
CAGG-39) or an AP-1 oligonucleotide probe (59-GGCAGCG-
CTTGATGACTCAGCCGAAA-39). Competition studies were
performed by adding a 33-fold excess of specific unlabeled NF-kB
probe or mutated NF-kB probe (59-GGCAGTTGAAGGC-
GACTTTCCCAGG-39).
Figure 6. Flagellin activates NF-kB in the heart and does not induce myocardial cell death in vivo. A–B, Flagellin increased
phosphorylation and degradation of IkBa, and nuclear p65 trasnlocation after 30 minutes in myocardial extracts. No differences were detected
between the two doses of flagellin (1 and 5 mg). C, Flagellin (1 and 5 mg) induced marked NF-kB-DNA binding activity in heart tissue after 30 minutes.
D, Specificity of the NF-kB-DNA binding. The band shift disappears in the presence of an excess of cold unmutated (U), but not mutated (M), probe. E,
Dose-response experiments. NF-kB-DNA binding activity (30 min after flagellin) significantly increased at 10 ng and further increased at 100 ng/
mouse. F, Time-course experiments. NF-kB-DNA binding induced by flagellin (1 or 5 mg) started to increase after 10 minutes. G, Cardiac troponin I was
not increased 4 hours after flagellin (Immunoassay). H, Myocardial cleavage of caspase-3 was strongly induced by 30 minutes ischemia and 3 hours
reperfusion (I/R, positive control), but was not detectable 4 to 24 hours after flagellin (1 mg). * p,0.05 versus control C (ANOVA followed by Dunnett
test).
doi:10.1371/journal.pone.0012687.g006
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Figure 7. Flagellin triggers the generation of pro-inflammatory cytokines in the mouse heart in vivo. Flagellin (1 mg) induced significant
increases of TNF-, IL-1, IL-6, MIP-2 and MCP-1 (A–E), but not soluble TREM-1 (F) in whole hearts from BALB/c mice (n = 5 mice per condition). Flagellin
also induced a modest, but significant increase of myeloperoxydase (MPO) activity in the heart after 4 h (G). Histologically, rare polymorphonuclear
(arrow) and mononuclear (arrowhead) leukocytes were found within cardiac blood vessels (H). Immunohistochemical studies revealed a slight
recruitment of Mac-3 positive mononuclear cells, located in the subepicardial region (I). * p,0.05 versus control C (ANOVA followed by Dunnett test
A to F; t-test, G). Histological pictures are representative of 3 mice/group. Scale bar size: 30 mm (H); 50 mm (I).
doi:10.1371/journal.pone.0012687.g007
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IKK kinase assay
IKK immunoprecipitation and kinase assay were performed as
mentioned [21].
NF-kB Luciferase Reporter Assay
Cells were transiently transfected with 1 mg of a multimeric NF-
kB pGL2 luciferase vector and 0.1 mg of the Renilla pRL-TK
vector using Lipofectamine, and luciferase activity measured as
described [20].
RNA Isolation and RT-PCR
RNA isolation and reverse transcription were performed as
described [21]. The sequences of the primer pairs for TNFa were
as mentioned [21], and for rat MIP-2 (sense, 59-
TTGTTGTGGCCAGTGAGCTGC-39; antisense, 59-AT-
CAGGT ACGATCCAGGCTTCC-39). A kit of mouse/rat
specific PCR primer pair was purchased for TLR5 (R&D Systems,
Minneapolis, MN).
Immunofluorescence studies
H9c2 cells were fixed, permeabilized with Triton X-100 0.1%,
blocked with goat serum, and incubated with normal rabbit serum
or a rabbit polyclonal anti-TLR5 (BioVision). Immunodetection
was performed using a goat anti-rabbit IgG secondary antibody
labeled with Oregon Green 488 (Invitrogen). Nuclei were
counterstained with DAPI.
Quantification of cytokine production
The levels of TNFa, IL-1b, IL-6, MIP-2, MCP-1, and TREM-1
(triggering receptor expressed on myeloid cells-1), were measured
in whole heart tissue by ELISAs (R&D Systems). MIP-2 was also
quantified in the supernatant of H9c2 cells. In addition, the levels
of TNFa, IL-1b and MIP-2 were also determined in liver and lung
extracts as well as in the plasma 1 h after the administration of
flagellin.
Myeloperoxidase Assay
MPO activity was determined in cardiac tissue as described
[22].
Histology and immunohistochemistry of the heart
Hearts were fixed in 4% paraformaldehyde, embedded in
paraffin, cut in 5 mm slice and stained with hematoxylin-eosin.
Deparaffinized sections were incubated (1 h) in 5% rabbit serum,
Figure 8. Flagellin induces widespread generation of pro-inflammatory cytokines. The levels of MIP-2 (A, B), TNFa (C, D) and IL-1b (E, F)
were determined by ELISA in the lung and liver (left panel) as well as in plasma (right panel) in control (C) and 1 h after systemic flagellin
administration (n = 3mice/group). A significant increase of these cytokines was detected both in organs and in plasma. *p,0.05 vs control C (t test).
doi:10.1371/journal.pone.0012687.g008
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and then overnight at 4uC with rat anti-mouse Mac-3 immuno-
globulin G1 at a 1/100 dilution (Pharmingen, BD Biosciences, San
Diego, CA), which reacts with the 110-kDa Mac-3 surface antigen
of mouse mononuclear phagocytes [37], followed by incubation
for 40 min with a rabbit anti-rat secondary antibody conjugated to
biotin (1/200, Vector, Burlingame, CA) and by 30 min incubation
with DAB kit (Vector).
Myocardial ischemia-reperfusion in rats
Myocardial ischemia was induced by transient (30 minutes)
ligation of the left anterior descending coronary artery, followed by
3 hours reperfusion, in anesthetized, mechanically ventilated rats,
according to our published procedures [22].
Hemodynamic measurements in mice
The experiments were performed 4, 24 and 48 hours after
flagellin (40 mg/kg, 1 mg/mouse) administration. The animals
were anesthetized (ketamine, 75 mg/kg; xylazine, 10 mg/kg) and
tracheotomized. A pressure-volume (PV) catheter (SPR-839;
Millar Instruments) was inserted into the left ventricle (LV) via
the right carotid artery. After stabilization for 20 minutes, heart
rate, LV systolic and end-diastolic pressures and volumes were
measured, and stroke volume, ejection fraction, and cardiac
output were calculated and corrected according to in vitro and in
vivo volume calibrations with a cardiac PV analysis program
(PVAN3.2; Millar Instruments). End-systolic LV PV relationships
were assessed by transiently reducing venous return by compress-
ing the inferior vena cava, and LV contractility was assessed from
the slope of the LV end-systolic PV relationship (end-systolic
elastance), calculated using PVAN3.2, as detailed previously [38].
Presentation of data and statistical analysis
All graphs summarize the results of at least 3 independent
experiments, and are presented as means 6 SEM. In experiments
comparing only 2 conditions, statistical analysis was done with
Student’s t-test. In experiments using multiple conditions,
comparison was done with analysis of variance (ANOVA) followed
by Dunnett post-hoc test when appropriate. A p value,0.05 was
considered significant.
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